ATNX - Athenex Inc
Close
0.2031
-0.062 -30.527%
Share volume: 0
Last Updated: Wed 24 May 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.27
-0.06
-23.39%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
| Report Date | 2022-05-10 | 2022-07-29 | 2022-11-03 | 2023-03-20 | |
| Cash flow financing | -25.369 M | 6.841 M | 20.780 M | 119.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -18.466 M | -18.345 M | -15.731 M | -11.806 M | |
| Net income | -17.420 M | -32.157 M | -19.669 M | -34.181 M | |
| Depreciation | 872.000 K | 598.000 K | 746.000 K | 106.000 K | |
| Changes in inventories | 41.253 M | 37.851 M | 42.039 M | 42.654 M | |
| Changes in receivables | 29.605 M | 33.824 M | 32.912 M | 27.865 M | |
| Investing Cashflow | -167.000 K | 8.627 M | -1.030 M | 106.000 K | |
| Net Borrowings | 79.931 M | 18.661 M | -3.168 M | -4.866 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -190.000 K | -838.000 K | -1.088 M | 56.000 K | |
| Cash Change | 37.459 M | 23.328 M | 36.221 M | 31.508 M |